These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
23. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial. Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289 [TBL] [Abstract][Full Text] [Related]
24. Blood-brain barrier injury and neuroinflammation induced by SARS-CoV-2 in a lung-brain microphysiological system. Wang P; Jin L; Zhang M; Wu Y; Duan Z; Guo Y; Wang C; Guo Y; Chen W; Liao Z; Wang Y; Lai R; Lee LP; Qin J Nat Biomed Eng; 2024 Aug; 8(8):1053-1068. PubMed ID: 37349391 [TBL] [Abstract][Full Text] [Related]
25. Biomimetic Human Disease Model of SARS-CoV-2-Induced Lung Injury and Immune Responses on Organ Chip System. Zhang M; Wang P; Luo R; Wang Y; Li Z; Guo Y; Yao Y; Li M; Tao T; Chen W; Han J; Liu H; Cui K; Zhang X; Zheng Y; Qin J Adv Sci (Weinh); 2021 Feb; 8(3):2002928. PubMed ID: 33173719 [TBL] [Abstract][Full Text] [Related]
26. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols. Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX Elife; 2021 Apr; 10():. PubMed ID: 33861198 [TBL] [Abstract][Full Text] [Related]
27. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents. Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711 [TBL] [Abstract][Full Text] [Related]
28. Modeling the viral dynamics of SARS-CoV-2 infection. Wang S; Pan Y; Wang Q; Miao H; Brown AN; Rong L Math Biosci; 2020 Oct; 328():108438. PubMed ID: 32771304 [TBL] [Abstract][Full Text] [Related]
29. Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load. Rajagopala SV; Strickland BA; Pakala SB; Kimura KS; Shilts MH; Rosas-Salazar C; Brown HM; Freeman MH; Wessinger BC; Gupta V; Phillips E; Mallal SA; Turner JH; Das SR J Virol; 2023 Feb; 97(2):e0147822. PubMed ID: 36656015 [TBL] [Abstract][Full Text] [Related]
30. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Maisonnasse P; Guedj J; Contreras V; Behillil S; Solas C; Marlin R; Naninck T; Pizzorno A; Lemaitre J; Gonçalves A; Kahlaoui N; Terrier O; Fang RHT; Enouf V; Dereuddre-Bosquet N; Brisebarre A; Touret F; Chapon C; Hoen B; Lina B; Calatrava MR; van der Werf S; de Lamballerie X; Le Grand R Nature; 2020 Sep; 585(7826):584-587. PubMed ID: 32698191 [TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 pathogenesis in an angiotensin II-induced heart-on-a-chip disease model and extracellular vesicle screening. Wu Q; Rafatian N; Wagner KT; Blamer J; Smith J; Okhovatian S; Aggarwal P; Wang EY; Banerjee A; Zhao Y; Nash TR; Lu RXZ; Portillo-Esquivel LE; Li CY; Kuzmanov U; Mandla S; Virlee E; Landau S; Lai BF; Gramolini AO; Liu C; Fleischer S; Veres T; Vunjak-Novakovic G; Zhang B; Mossman K; Broeckel U; Radisic M Proc Natl Acad Sci U S A; 2024 Jul; 121(28):e2403581121. PubMed ID: 38968108 [TBL] [Abstract][Full Text] [Related]
32. Comparative Analysis of Viral Load and Cytokines during SARS-CoV-2 Infection between Pregnant and Non-Pregnant Women. Liu D; Li H; Li X; Rodriguez GD; Pietz H; Fiel RH; Konadu E; Singh V; Loo F; Rodgers WH Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062978 [TBL] [Abstract][Full Text] [Related]
33. An update on microfluidic multi-organ-on-a-chip systems for reproducing drug pharmacokinetics: the current state-of-the-art. Vasconez Martinez MG; Frauenlob M; Rothbauer M Expert Opin Drug Metab Toxicol; 2024 Jun; 20(6):459-471. PubMed ID: 38832686 [TBL] [Abstract][Full Text] [Related]
34. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants. Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303 [TBL] [Abstract][Full Text] [Related]
35. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets. Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK mBio; 2020 May; 11(3):. PubMed ID: 32444382 [TBL] [Abstract][Full Text] [Related]
36. Biomimetic lung-on-a-chip to model virus infection and drug evaluation. Tan J; Guo Q; Tian L; Pei Z; Li D; Wu M; Zhang J; Gao X Eur J Pharm Sci; 2023 Jan; 180():106329. PubMed ID: 36375766 [TBL] [Abstract][Full Text] [Related]
37. COVID-19 - prime time for microphysiological systems, as illustrated for the brain. Kang I; Smirnova L; Kuhn JH; Hogberg HT; Kleinstreuer NC; Hartung T ALTEX; 2021; 38(4):535-549. PubMed ID: 34698363 [TBL] [Abstract][Full Text] [Related]
39. Long-Term Modeling of SARS-CoV-2 Infection of Hao S; Ning K; Kuz CA; Vorhies K; Yan Z; Qiu J mBio; 2020 Nov; 11(6):. PubMed ID: 33158999 [TBL] [Abstract][Full Text] [Related]
40. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial. García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]